HealthcareServices

Organoids And Spheroids Industry Overview 2025: Growth Projections and Market Trends

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Organoids And Spheroids Market Size During 2025–2029?

The organoids and spheroids market size has seen remarkable growth in recent years. Projections indicate it will expand from $1.16 billion in 2024 to $1.44 billion in 2025, achieving a compound annual growth rate (CAGR) of 24.3%. This growth in the past period is attributable to several factors, including swift advancements in stem cell research and 3D cell culture technologies, increased funding and investments, a rise in chronic diseases, broader application of organoids and spheroids in drug screening and toxicology studies, progress in regenerative medicine and personalized medicine approaches, and favorable regulatory frameworks that support the use of advanced cell culture models in research.

The organoids and spheroids market is projected to experience substantial expansion in the coming years, with its size forecast to reach $3.44 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 24.3%. This anticipated growth throughout the forecast period stems from continuous technological advancements, the broadening scope of personalized medicine, enhanced utility in cancer research, the evolution of ethical and regulatory frameworks, an increase in commercial products and services based on organoid and spheroid technologies, and heightened educational initiatives aimed at training researchers in these fields. Key trends expected in this period include the integration with advanced technologies, the expansion of high-throughput screening methods utilizing organoids for drug discovery, progress in 3D bioprinting and biofabrication, the increasing application of organoids for modeling various cancers, and their incorporation into microfluidic systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18421&type=smp

What Are The Main Drivers Boosting The Organoids And Spheroids Industry’s Expansion?

The escalating demand for cell therapy and tissue engineering is projected to propel the growth of the organoids and spheroids market moving forward. Cell therapy and tissue engineering involve utilizing living cells or engineered tissues to replace, repair, or regenerate damaged tissues and organs in the body. The demand for these therapies is increasing due to their potential to regenerate impaired tissues and treat conditions previously considered incurable, thereby offering innovative solutions in regenerative medicine. Organoids and spheroids are employed in cell therapy and tissue engineering for modeling complex tissues and testing therapeutic approaches in vitro. For instance, in February 2023, according to Cell & Gene, a US-based online resource for research scholars, there were 27 FDA-approved cell and gene therapies (CGTs), making up about 8% of the 340 approved biologics in 2022, an increase from 22 approved in 2021. This growing demand for cell therapy and tissue engineering is anticipated to fuel the expansion of the organoids and spheroids market.

How Is The Organoids And Spheroids Market Segmented?

The organoids and spheroidsmarket covered in this report is segmented –

1) By Type: Organoids; Spheroids

2) By Method: Extracellular Matrix Scaffold Method; Spinning Bioreactor Method; Hanging Drop Method; Low Adherent Culture Plate Method; Magnetic levitation Method; Other Methods

3) By Application: Developmental Biology; Personalized Medicine; Regenerative Medicine; Disease Pathology Studies; Drug Toxicity And Efficacy Testing

4) By End User: Biotechnology And Pharmaceutical Industry; Academic And Research Institutes; Hospitals And Diagnostic Centers

Subsegments:

1) By Organoids: Intestinal Organoids; Liver Organoids; Brain Organoids; Kidney Organoids; Lung Organoids; Pancreatic Organoids; Cardiac Organoids; Retinal Organoids; Tumor Organoids; Organoids For Disease Modeling

2) By Spheroids: Cancer Spheroids; Neural Spheroids; Cardiac Spheroids; Liver Spheroids; Muscle Spheroids; Endothelial Spheroids; Stem Cell-Derived Spheroids; 3D Cell Culture Spheroids

What Trends Are Redefining The Organoids And Spheroids Market Dynamics?

Key companies operating in the organoids and spheroids market are concentrating on developing sophisticated solutions, like single-particle dispensers, to boost accuracy in cell manipulation and enhance the reliability of research findings. Single-particle dispensers are precise devices crafted to isolate and distribute individual cells or particles, enabling exact control and handling in research and diagnostic fields. For instance, in July 2024, SEED Biosciences, a Switzerland-based biotechnology company, launched Dispen3D, a revolutionary instrument engineered for the accurate dispensing of individual spheroids and organoids, marking a significant advancement in managing 3D cellular models. Researchers can now swiftly and precisely transfer single spheroids into multi-well plates with this novel dispenser, which automates the procedure and ensures monoclonality, a critical factor for drug discovery and customized treatment. Dispen3D delicately handles fragile cells while maintaining their structural integrity and vitality by operating at low pressures. Its intuitive design makes it simple to implement across diverse research contexts, addressing the growing demand for cutting-edge instruments in the biological sciences.

Which Major Industry Participants Are Leading The Organoids And Spheroids Market Growth?

Major companies operating in the organoids and spheroids market are Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, StemCell Technologies Canada Inc., Greiner Bio-One International AG, Promega Corporation, Molecular Devices LLC, American Type Culture Collection (ATCC), Mimetas B.V., InSphero AG, HUB Organoids, Emulate Inc., 3D Biomatrix Inc., Prellis Biologics Inc., 3D Biotek LLC, DefiniGEN Limited, Visikol Inc., Organovo Holdings Inc., Cellesce Ltd., AMS Biotechnology (Europe) Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/organoids-and-spheroids-global-market-report

What Regional Growth Trends Are Shaping The Organoids And Spheroids Market Outlook?

North America was the largest region in the organoids and spheroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoids and spheroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Organoids And Spheroids Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18421&type=smp

Browse Through More Reports Similar to the Global Organoids And Spheroids Market 2025, By The Business Research Company

Fertilizer Additives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fertilizer-additives-global-market-report

Controlled Release Fertilizer Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/controlled-release-fertilizer-global-market-report

Biofertilizers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biofertilizers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795